Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-14T19:21:03.915Z Has data issue: false hasContentIssue false

Prevalence of intramammary infections by major pathogens at parturition in dairy cows after intramuscular antibiotic therapy at drying-off: a preliminary report

Published online by Cambridge University Press:  09 May 2003

Héctor Tarabla
Affiliation:
Instituto Nacional de Tecnología Agropecuaria, Estación Experimental Agropecuaria Rafaela, CC 22, 2300 Rafaela, Santa Fe, Argentina Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral Esperanza, Santa Fe, Argentina
Vilma Canavesio
Affiliation:
Instituto Nacional de Tecnología Agropecuaria, Estación Experimental Agropecuaria Rafaela, CC 22, 2300 Rafaela, Santa Fe, Argentina

Abstract

In dry cow therapy (DCT), antibiotics are usually injected direct into the mammary gland after the last milking of the lactation. Most products are designed to eliminate existing intramammary infections (IMI) caused by Staphylococcus aureus and Streptococcus agalactiae and to prevent the establishment of new IMI caused by major pathogens during the early non-lactating period (Nickerson et al. 1999). Systemic therapy has been attempted as a way of improving the cure rates of intramammary treatments of clinical and subclinical mastitis during lactation (Ziv, 1980a; Calvinho et al. 1988; Owens et al. 1988). For systemic therapy to be useful, effective passage of the drug from blood to the foci of infection must be achieved. Maintaining an effective antibacterial concentration in the udder depends on the physicochemical properties of the drug, the dose, the bioavailability of the injected formulation, and the sensitivity of the pathogen (Ziv et al. 1980a, b). The theoretical pharmacokinetic and pharmacodynamic basis for systemic DCT has been reported (Soback, 1988). When used in an attempt to improve cure rates of IMI, subcutaneous injection of tilmicosin at drying-off was ineffective against Staph. aureus IMI (Nickerson et al. 1999) and intramuscular (i.m.) oxytetracycline, in combination with intramammary cephapirin dry-cow treatment did not improve the cure rate for Staph. aureus mastitis (Soback et al. 1990a; Erskine et al. 1994). Nevertheless, i.m. tylosin treatment 2 weeks before the expected day of calving decreased IMI after calving (Zecconi et al. 1999) and subcutaneous norfloxacin nicotinate applied at the cessation of milking proved useful in controlling Staph. aureus infections (Soback et al. 1990a). Moreover, the incidence of this pathogen after systemic DCT may be significantly lower compared with untreated control groups (Soback et al. 1990a, b).

Type
Brief Report
Copyright
Proprietors of Journal of Dairy Research 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)